Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

IMPORTANCE: Hydroxychloroquine, with or without azithromycin, has been considered as a possible therapeutic agent for patients with coronavirus disease 2019 (COVID-19). However, there are limited data on efficacy and associated adverse events. OBJECTIVE: To describe the association between use of hy...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA
Hlavní autoři: Rosenberg, Eli S., Dufort, Elizabeth M., Udo, Tomoko, Wilberschied, Larissa A., Kumar, Jessica, Tesoriero, James, Weinberg, Patti, Kirkwood, James, Muse, Alison, DeHovitz, Jack, Blog, Debra S., Hutton, Brad, Holtgrave, David R., Zucker, Howard A.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2020
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7215635/
https://ncbi.nlm.nih.gov/pubmed/32392282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2020.8630
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky